CBDD Company Profile and Key Details

Average 10-day trading volume of 88.34 thousand shares is below the 3-month average of 4.79 million, indicating normal recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

The stock is currently trading near its 52-week low $0.00 and $0.00. With a market capitalization of about $1.07 million, CBD of Denver, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-8.68). Key stats such as the average daily volume over the past year has been around 4.27 million shares, in line with its 52-week average. Headquartered in Centennial, CO, CBD of Denver, Inc. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Jan Schwager, the company employs approximately 2 people and listed since May 15, 1996. CBD of Denver, Inc. engages in the cultivation, production, and distribution of cannabis flower and CBD products in Switzerland, Europe, and the US.

Valuation shows CBD of Denver Inc. trading at a premium to the broader market with a P/E of -10.54.

Our AI price prediction model suggests that CBD of Denver Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

CBD of Denver Inc. trades at a P/E ratio of -10.54, slightly below the S&P 500 average, with a price-to-sales ratio of 1.82 and a price-to-book ratio of -0.83 indicating negative book value, which may reflect financial stress. The P/FCF stands at 30.51, also above market averages.